SLC5A2 and diabetic retinopathy: For diabetic retinopathy, GLP-1RAs are associated with the ‘early worsening’ phenomenon linked to rapid glycemic control, a signal not typically observed with SGLT2 inhibitors, which generally show a neutral or modestly protective effect.